Large-scale testing (Phase 3)UnknownNCT02646137What this trial is testingSingle Session Combined Locoregional Therapies for Hepatocellular CarcinomaWho this might be right forLiver Cancer Sherief Abd-Elsalam 50
Not applicableLooking for participantsNCT04657042What this trial is testing4D-MRI for Precision MedicineWho this might be right forHealthy VolunteersLiver CancerLung Cancer University of Virginia 100
Early research (Phase 1)Study completedNCT00960557What this trial is testingSafety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor BurdenWho this might be right forNeoplasm Metastasis Mateon Therapeutics 16
Not applicableStudy completedNCT03813953What this trial is testingThe Effect of Analgesic Modalities on Long Term Outcomes Following Open Liver ResectionWho this might be right forLiver Cancer University of Edinburgh 160
Not applicableStudy completedNCT02722395What this trial is testingMagnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)Who this might be right forPrimary Liver CancerMetastatic Liver Cancer From Any Cancer Site Duke University 5
Not applicableWithdrawnNCT03452553What this trial is testingStudy in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With DoxorubicinWho this might be right forHepatocellular Carcinoma (HCC) Boston Scientific Corporation
Not applicableLooking for participantsNCT06877637What this trial is testingOn-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver CancerWho this might be right forHepatocellular Carcinoma (HCC)Cholangiocarcinoma Region Skane 150
Testing effectiveness (Phase 2)WithdrawnNCT03484962What this trial is testingStudy of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver CancerWho this might be right forAdvanced Liver Cancer Fuda Cancer Hospital, Guangzhou
Not applicableLooking for participantsNCT05199259What this trial is testingMulti-analyte Blood Test Clinical TrialWho this might be right forLiver CirrhosisLiver CancerHCC+1 more Helio Genomics 1,200
Not applicableStudy completedNCT04257240What this trial is testingRecurrence of Liver Malignancy After Ischemia/Reperfusion InjuryWho this might be right forIschemic Reperfusion InjuryLiver InjuryCancer Recurrence+2 more Aretaieion University Hospital 230
Not applicableStudy completedNCT00002485What this trial is testingDevelopment of Strategies to Increase Enrollment in Clinical Trials for Children With CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more Children's Oncology Group 359
Testing effectiveness (Phase 2)Study completedNCT03058289What this trial is testingA Phase 1/2 Safety Study of Intratumorally Dosed INT230-6Who this might be right forBreast CancerHead and Neck CancerSquamous Cell Carcinoma+8 more Intensity Therapeutics, Inc. 111
Testing effectiveness (Phase 2)Study completedNCT03199274What this trial is testingPerflutren Protein-Type A Microspheres and Contrast-Enhanced Ultrasound in Improving Response to Radioembolization Therapy in Patients With Liver CancerWho this might be right forHepatocellular Carcinoma Thomas Jefferson University 104
Testing effectiveness (Phase 2)Study completedNCT02431676What this trial is testingSurvivorship Promotion In Reducing IGF-1 TrialWho this might be right forBreast CancerProstate CancerLung Cancer+8 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 121
Testing effectiveness (Phase 2)Study completedNCT00005938What this trial is testingDX-8951f in Treating Patients With Biliary CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer Daiichi Sankyo
Early research (Phase 1)Ended earlyNCT03349255What this trial is testingClinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaLiver CancerLiver Neoplasms+1 more Aeon Therapeutics (Shanghai) Co., Ltd. 3
Testing effectiveness (Phase 2)Study completedNCT01033240What this trial is testingCS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver CancerWho this might be right forAdvanced Hepatocellular CarcinomaLiver CancerHepatic Cancer+1 more Daiichi Sankyo 172
Testing effectiveness (Phase 2)Looking for participantsNCT06492408What this trial is testingNeoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.Who this might be right forHepatic CancerSurgery Second Affiliated Hospital of Guangzhou Medical University 90
Not applicableStudy completedNCT07204262What this trial is testingTrajectory-Based Prognostic Modeling in Hepatocellular CarcinomaWho this might be right forLiver Cancer Xu Yong, MD 379
Not applicableUnknownNCT01341210What this trial is testingObservational Study of the Decision Making Towards Clinical Trials in Cancer PatientsWho this might be right forLung CancerLiver Cancer National Taiwan University Hospital 116